Just to jump in on the conversation.
There may well end up being one OBD for IT (injected into the tumour) and another for IV (into the bloodstream). With IV being higher due to its dispersal.
I believe they're quite keen to pump the IV rates to see how high they can go due to the convenience and also the body wide effectiveness and possible access to diffic ult to reach tumours.
Provided they can get it to be nicely effective at higher doses. Which I'm relatively confident in based on trial to date results.
Just my thoughts. I'll go back to lurking and ignoring.
Why IMU is a multi multi bagger, page-19235
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $508.7M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $1.427M | 20.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 57517 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 667419 | 9 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 0.29 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 7.1¢ | 6.8¢ | 7149293 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| IMU (ASX) Chart |